Korean Circ J.  2019 Apr;49(4):361-362. 10.4070/kcj.2019.0023.

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension

• Kim HY
• Kim KH

• KMID: 2441140
• DOI: http://doi.org/10.4070/kcj.2019.0023

Abstract

No abstract available.

MeSH Terms

Hypertension*

Reference

1. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012; 142:448–456.

2. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37:67–119.

3. Yoon KL. New therapeutic target for pulmonary arterial hypertension. Korean Circ J. 2018; 48:1145–1147.

4. Kang SG, Kim JJ. Udenafil: efficacy and tolerability in the management of erectile dysfunction. Ther Adv Urol. 2013; 5:101–110.

5. Kim KH, Kim HK, Hwang IC, et al. ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial. Trials. 2013; 14:188.

6. Kreisel W, Deibert P, Kupcinskas L, et al. The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Dig Liver Dis. 2015; 47:144–150.

7. Kim HL, Kim YJ, Kim KH, et al. Therapeutic effects of udenafil on pressure-overload cardiac hypertrophy. Hypertens Res. 2015; 38:597–604.

8. Chang SA, Kim HK, Chang HJ, Kim DK. Acute hemodynamic changes after single administration of udenafil in pulmonary arterial hypertension: a phase IIa study. Korean Circ J. 2019; 49:353–360.

9. Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005; 353:2148–2157.

10. Galiè N, Brundage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009; 119:2894–2903.